Found 32 matching trials
68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease
EARLY_PHASE1This study is a prospective, case-control study evaluating whether the PET ...
Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma
PHASE2This phase II trial tests whether 68Ga-FAPI-46 positron emission tomography...
Location
Mayo Clinic in Rochester
Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma
PHASE2This is a prospective, multi-center, single arm, open label, non-randomized...
Location
University of California Los Angeles (UCLA) Health
18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.
PHASE2The extent of breast cancer is an important prognostic factor in patients d...
Location
Maastricht University Medical Center+
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
PHASE1This phase I trial is evaluating a new imaging tracer (68Ga-FAPi-46) with p...
Status
Active Not Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients
EARLY_PHASE1This pilot study aims to compare PET/CT imaging using 68Ga-FAPI-46 to imagi...
Location
Vanderbilt University Medical Center
68Ga-FAPI-46 PET for Imaging of FAP Expressing Cancer
PHASE2This study is to explore the safety and tolerability as well as diagnostic ...
Location
Department of Nuclear medicine, University hospital Essen
68Gallium-FAPI46 PET/CT Imaging in Chronic Inflammatory and Fibrotic Diseases
NAThis single-center pilot study is designed to explore the preliminary utili...
Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer
NAThis is a prospective, single-center, single arm, open label study to evalu...
Location
Department of Nuclear Medicine, Chang Gung Memorial Hospital
Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases
PHASE2To evaluate the effect of an anti-fibrotic treatment initiation on the fibr...